People choose a combined potassium magnesium supplement over two separate products for three reasons: the two minerals regulate each other physiologically, most adults fall short on potassium and nearly half of Americans fall short on magnesium, and one product is easier to take consistently than two. The physiological case is the strongest. Magnesium depletion increases urinary potassium loss, and low potassium is often difficult to correct until magnesium status is restored. The convenience case is real but secondary. The evidence for a combined product outperforming the same doses taken separately is limited, and a combination is not appropriate for everyone. This article sets out what the science supports, where the evidence stops, and what combining the two minerals means for product developers working in capsules, powders, gummies, and beverages.

Why potassium and magnesium are paired

Magnesium controls how much potassium the kidneys retain

Potassium is the most abundant intracellular cation and magnesium is a cofactor in more than 300 enzyme systems, including the Na+/K+-ATPase pump that moves potassium into cells. The two minerals are physiologically linked at the kidney. According to the NIH Office of Dietary Supplements (ODS), magnesium depletion contributes to hypokalemia by increasing urinary potassium losses, and more than 50% of individuals with clinically significant hypokalemia might have magnesium deficiency. The ODS fact sheet also states that people with both hypomagnesemia and hypokalemia should have both conditions treated concurrently.

Huang and Kuo (Journal of the American Society of Nephrology, 2007) describe how intracellular magnesium normally blocks the ROMK potassium channel in the distal nephron. When intracellular magnesium falls, that inhibition weakens, potassium secretion into urine increases, and potassium repletion alone fails to restore normal levels. Later channel studies confirmed that physiological magnesium concentrations modulate ROMK-mediated potassium secretion. In practical terms, a person with low magnesium who takes potassium alone may excrete much of it.

This link is the primary scientific rationale for pairing the two minerals. It matters most in states where magnesium loss is plausible: gastrointestinal disease, type 2 diabetes, alcohol dependence, and older age, the groups the ODS magnesium fact sheet identifies as at risk of magnesium inadequacy, as well as diuretic use.

Intake shortfalls for both minerals overlap

The shortfalls overlap, which is why a single product addressing both is a rational design choice. The ODS reports that dietary surveys consistently show U.S. residents consume less potassium than recommended, which is why the Dietary Guidelines for Americans identify potassium as a nutrient of public health concern. Average intake from food is 3,016 mg per day for adult men and 2,320 mg for adult women, against Adequate Intakes of 3,400 mg and 2,600 mg respectively. For magnesium, an analysis of NHANES 2013 to 2016 data found that 48% of Americans of all ages consume less magnesium from food and beverages than their Estimated Average Requirement. Adult RDAs range from 310 to 420 mg per day depending on age and sex.

The same dietary pattern drives both gaps. CDC analysis identifies fruits, vegetables, and dairy as the top contributors to potassium intake, and the ODS lists green leafy vegetables, legumes, nuts, seeds, and whole grains as good sources of magnesium. A diet low in plant foods tends to be low in both.

Both minerals independently support normal blood pressure

Potassium and magnesium each have randomized trial evidence for modest blood pressure reduction. A meta-analysis of 15 randomized controlled trials cited by the ODS found that potassium supplements of roughly 2,346 to 2,541 mg per day reduced systolic blood pressure by a mean of 6.8 mmHg and diastolic by 4.6 mmHg in 917 participants not taking antihypertensive medication. For magnesium, a systematic review and subgroup meta-analysis in normotensive adults found that magnesium supplementation at doses up to 360 mg per day for more than three months lowered systolic blood pressure, with the strongest effects at longer durations.

The evidence for combined supplementation is thinner. The same review notes that trials of combined potassium and magnesium supplementation are few and results are mixed, and an earlier pooled analysis of three small trials did not reach statistical significance. In summary, both minerals contribute to blood pressure regulation, but there is no large trial demonstrating that a combined product produces a larger effect than the same doses taken separately. Claims of synergy are not supported by current data.

One product is easier to take than two

Adherence is the practical reason consumers reach for combinations. Fewer daily units reduce pill burden, a consumer preference we discussed in Tired of Taking Pills? You're Not Alone. A combined product also standardizes the ratio between the two minerals, so a consumer does not have to work out compatible doses across two labels.

When separate supplements make more sense

A combination product is not the correct choice in every case. Three situations favor separate dosing or medical supervision.

• Clinically diagnosed hypokalemia. Dietary supplements typically provide 99 mg or less of potassium per serving, about 2% of the 4,700 mg Daily Value used on labels. Diagnosed hypokalemia is managed under medical supervision, and clinical guidance stresses correcting coexisting magnesium deficiency as part of that treatment.

• Kidney disease or medications that raise potassium. The ODS notes that ACE inhibitors, angiotensin receptor blockers, and potassium-sparing diuretics reduce urinary potassium excretion and can cause hyperkalemia. Individuals with impaired kidney function or on these medications should not add potassium without medical advice, even at supplement doses.

• Different dose targets. Someone who needs 300 to 350 mg of supplemental magnesium but only a small amount of potassium may find that combination products underdeliver on magnesium, because the fixed ratio is set by the potassium limit rather than the magnesium target.

Regulatory limits that shape combination products

Two rules define the dose window for a potassium magnesium supplement in the United States.

Potassium: the 99 mg convention. 21 CFR 201.306 is an FDA drug regulation covering oral potassium salt preparations. It permits regulatory action against uncoated tablets supplying 100 mg or more of potassium per tablet, and liquid preparations supplying 20 mg or more per milliliter, unless they carry prescription labeling. It also requires warnings about small-bowel lesions on coated potassium tablets. The regulation applies to drugs, and the ODS notes that FDA has not ruled on whether dietary supplements above 99 mg must carry a warning. Many manufacturers nonetheless cap potassium at 99 mg per serving to stay clear of the drug threshold, which is why potassium-only and combination supplements cluster at that figure. The Supplement Facts panel must declare elemental potassium, not the weight of the salt.

Magnesium: the 350 mg supplemental UL. The Food and Nutrition Board set a Tolerable Upper Intake Level of 350 mg per day for supplemental magnesium in adults and children aged 9 and older. The UL applies only to magnesium from supplements and medications, not food, because excess supplemental magnesium causes diarrhea, nausea, and abdominal cramping. Products that suggest multiple servings per day need to account for the cumulative total.

The result is a narrow design space: roughly 99 mg of potassium alongside anywhere from 50 to 350 mg of magnesium, with the ratio driven by regulation rather than physiology.

Formulation realities of combining the two minerals

Once the dose window is fixed, the remaining decisions concern which salts to use and which format can carry them. These choices determine bioavailability, taste, and stability.

Mass and elemental content

Mineral salts carry very different proportions of elemental mineral, and this dictates how much material a dose requires. Potassium chloride is about 52% potassium by weight, so 99 mg of potassium requires roughly 190 mg of salt. Potassium citrate is about 38% potassium and potassium gluconate about 17%, so the same dose requires around 260 mg and 590 mg respectively. On the magnesium side, magnesium oxide is about 60% magnesium, while magnesium citrate, malate, and bisglycinate fall roughly in the 11% to 16% range depending on the salt and its hydration state. Delivering 300 mg of magnesium requires roughly 500 mg of oxide but 1.9 to 2.7 g of a chelated or organic form.

This is why many capsule and tablet combinations default to magnesium oxide and potassium chloride: together they fit in one or two units. The trade-off is bioavailability. The ODS states that small studies have found magnesium in the aspartate, citrate, lactate, and chloride forms is absorbed more completely and is more bioavailable than magnesium oxide and magnesium sulfate, and Lindberg and colleagues (1990) showed that magnesium citrate produced significantly higher urinary magnesium excretion than an equivalent oxide dose, indicating greater absorption. For potassium, a 2016 dose-response trial found that about 94% of potassium gluconate is absorbed, comparable to potassium from potatoes. Our guide to common magnesium types and their water solubility covers the individual forms in more depth.

Solubility and taste in powders and beverages

Moving a potassium magnesium supplement into a stick pack, RTD drink, or gummy removes the capsule mass constraint but introduces sensory and stability problems. Magnesium oxide is practically insoluble in water and settles as a chalky sediment, so beverage formulators typically switch to citrate, chloride, malate, or bisglycinate. Those forms dissolve, but they also carry taste: magnesium salts are commonly described as bitter, astringent, or metallic at supplement-relevant concentrations. Potassium chloride, the least expensive and most compact potassium source, has a well-documented bitter and metallic note; sensory research on KCl-based salt substitutes shows bitterness intensifying as the KCl proportion rises. Potassium citrate and gluconate are milder but require more mass per milligram of potassium.

Matrix interactions add a second layer. Free magnesium ions react with phosphates, carbonates, polyphenols, and proteins to form haze or precipitate, and magnesium hydroxide precipitates at high pH. Chelated forms reduce the free ion concentration and so reduce these reactions, which is one reason bisglycinate and malate appear frequently in clear beverages despite their lower elemental density. As we noted in What Makes a Functional Drink Actually Functional?, chalkiness from minerals and sediment at the bottom of the bottle are among the sensory failures that most reliably undermine consumer acceptance.

Format comparison

• Capsules and tablets. Compact, stable, and largely taste-neutral. Favor high-density salts (oxide, chloride) at the expense of bioavailability. One to two units per serving for 99 mg potassium plus 200 to 300 mg magnesium.

• Powders and stick packs. No mass ceiling, so higher-bioavailability forms are feasible. Require soluble salts, flavor and acid systems to cover bitterness, and moisture control for hygroscopic salts such as magnesium chloride.

• RTD beverages and shots. The format most commonly used for electrolyte positioning. Demand soluble, matrix-compatible mineral forms that survive pasteurization, pH adjustment, and in some cases carbonation without sediment or haze across shelf life.

• Gummies. Popular with consumers but limited by payload per piece, which constrains the mineral dose each gummy can carry. We examined the same dose-per-piece constraint in our analysis of creatine gummies.

Where ingredient technology fits

The shift from pills to powders, shots, and RTD beverages is what makes mineral solubility a commercial question rather than a secondary consideration. Our work at Infusd addresses this by converting hard-to-solubilize actives, including magnesium, into water-soluble liquid and powder ingredients using a physical processing method with natural stabilizers, without synthetic emulsifiers. Those ingredients dissolve with minimal agitation, remain stable through pasteurization and carbonation, and carry a minimum 24-month shelf stability in real-time studies. For a development team building an electrolyte beverage or hydration shot, a water-soluble magnesium ingredient of this kind is designed to reduce the sediment, haze, and taste issues described above; suitability in a specific matrix is confirmed in application testing. Details on supported formats are on our applications page, and development teams can discuss specific matrices through Formulate with Us.

Frequently Asked Questions

Is it better to take potassium and magnesium together?

For most people with normal kidney function, taking them together is reasonable and physiologically coherent, because magnesium supports potassium retention and the two are commonly low at the same time. There is no strong evidence that a combined product works better than the same doses taken separately. The advantages are convenience and a fixed ratio, not a proven synergistic effect.

Why do potassium magnesium supplements contain only 99 mg of potassium?

Manufacturers cap potassium at 99 mg per serving to stay below the 100 mg per tablet threshold in FDA regulation 21 CFR 201.306, which governs oral potassium drug products and requires warning labels about small-bowel injury above that level. The rule applies to drugs, and FDA has not ruled on whether supplements above 99 mg need a warning, but many manufacturers treat 99 mg as the practical ceiling. At 99 mg, a serving provides about 2% of the 4,700 mg Daily Value.

How much magnesium should be in a combined supplement?

The Tolerable Upper Intake Level for supplemental magnesium is 350 mg per day for adults, so combined products typically provide between 100 and 350 mg. Doses above the UL from supplements can cause diarrhea and cramping. Food magnesium does not count toward this limit.

Which forms of potassium and magnesium are best in a combination product?

The answer depends on format. Capsules favor compact salts such as potassium chloride and magnesium oxide, though magnesium oxide is less bioavailable than citrate, chloride, lactate, or aspartate according to the NIH Office of Dietary Supplements. Powders and beverages require soluble forms such as magnesium citrate, malate, or bisglycinate and potassium citrate or gluconate, which are milder in taste but require more mass per milligram of mineral.

Who should avoid a potassium magnesium supplement?

People with chronic kidney disease, those taking ACE inhibitors, angiotensin receptor blockers, or potassium-sparing diuretics, and anyone with diagnosed hyperkalemia should not take supplemental potassium without medical guidance. Magnesium supplements can also interact with bisphosphonates, certain antibiotics, and proton pump inhibitors. A healthcare provider can assess whether either mineral is appropriate.

Can potassium and magnesium be delivered in a drink instead of a pill?

Yes. Beverages remove the capsule mass constraint that forces pills toward low-bioavailability salts, and they suit electrolyte positioning. The formulation challenge shifts to solubility, taste, and stability: mineral salts can be bitter or metallic, and free magnesium ions can precipitate with phosphates, proteins, or polyphenols. Soluble, matrix-compatible mineral forms and appropriate flavor systems are required for a clear, stable product.

This article is for educational purposes and does not constitute medical advice. Potassium and magnesium supplements can interact with medications and are not appropriate for people with certain kidney or cardiac conditions. Consult a qualified healthcare provider before starting any new supplement.